In this case study, learn how Dr. Elsa Wagner from Pierre Fabre Laboratories put together a comprehensive developability platform for monoclonal antibodies (mAbs), using combined thermal and colloidal stability parameters from the Prometheus Panta instrument.

You’ll learn about: 

• How Pierre Fabre Laboratories approaches developability assessment for mAbs candidates  
• The criteria that guided her decision for the Prometheus Panta as a solution for her developability platform 
• The benefits of combining simultaneous thermal and colloidal stability measurements for confident ranking of mAbs candidates

Brought to you by